Our flow cytometry data revealed that compared with OMT or DDP alone treatment, co-treatment OMT with DDP significantly increased CD8+ T cells percentage in PBMCs and spleen lymphocytes, and decreased Tregs cells percentage in PBMCs and tumor infiltrating lymphocytes (Figures 3A–C). This evidence concerns the gene CD8A and neoplasm.